Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Cancer Res. 2012 Jan 19;72(5):1070–1080. doi: 10.1158/0008-5472.CAN-11-3218

Figure 2. Immunotype frequency, prognosis, and cellular composition.

Figure 2

(A) The proportion of patients with each immunotype, in the first surgical specimen in the TMA, (B) Kaplan-Meier survival estimates for patients with each Immunotype, (C) Mean numbers of each immune cell subset, by Immunotype, and for all patients, (D) Proportion of mean total immune cells infiltrating tumor that are represented by each cell subset, by Immunotype.